Grund Nicholas (CIK 1661887) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-04). Recent activity: Sell AKBA (31,244 shares), Sell AKBA (53,585 shares), Buy AKBA (204,000 shares), Sell AKBA (55,621 shares), Buy AKBA (194,900 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | Chief Commercial Officer | Sell | 31,244 | $43,429 |
| 2026-02-04 | Akebia Therapeutics, Inc. (AKBA) | Chief Commercial Officer | Sell | 53,585 | $74,483 |
| 2026-02-03 | Akebia Therapeutics, Inc. (AKBA) | Chief Commercial Officer | Buy | 204,000 | $0 |
| 2025-02-04 | Akebia Therapeutics, Inc. (AKBA) | Chief Commercial Officer | Sell | 55,621 | $116,804 |
| 2025-02-04 | Akebia Therapeutics, Inc. (AKBA) | Chief Commercial Officer | Buy | 194,900 | $0 |
Source: SEC Form 4 filings · as of 2026-02-04